Why glioblastoma keeps beating treatment: Hidden signaling axis could open new drug path

Article excerpt

Researchers at the University of Ottawa have identified a previously unknown cellular signaling pathway that may explain why glioblastoma, the deadliest form of brain cancer in adults, resists standard treatments. The international team's discovery of this hidden axis could lead to new drug development strategies to overcome the tumor's defenses. Glioblastoma remains one of the most aggressive cancers, with survival rates among the poorest of any malignancy. The finding opens what the researchers describe as new frontiers in understanding why current therapies fail so often and how future treatments might be designed to target this specific mechanism.